The MHRA has issued CAS alerts on medicine supply shortages of Ranitidine and Theophylline.
Ranitidine – Tablets, effervescent tablets, oral solutions and ranitidine injection are all expected to shortly be out of stock with no date for resupply until further notice. Read more here.
Theophylline (Slo-phyllin) – Manufacture of this product has ceased, and is anticipated to be out of stock by the end of November. Read more here